It is a pharma private limited company based in New Delhi, Delhi, India, established in 2000.
2000 | New Delhi, Delhi, India | ActiveSymbiotic Therapeutics Private Limited, a active private limited company, was established on 23 June 2000 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U51109DL2000PTC106441. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹3.00 M.
It upholds a compliant status. Employing 144 professional, Its leadership includes Bhupender Kaushal (Director), Sanjay Guleria (Director). Past directors included Kalpana Kaushal, Bhupender Kaushal, Babita Guleria. It holds ₹9.50 M open charges and ₹2.20 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 305Mahajan Tower Plot No 7 L.Sc Shreshtha Vihar, New Delhi, Delhi, 110092.
U51109DL2000PTC106441
106441
23 June 2000
₹3.00 M
₹3.00 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Symbiotic Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bhupender Kaushal | Director | 23 Jun 2000 | Current |
| Sanjay Guleria | Director | 23 Jun 2000 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Aug 2009 | Past |
| Pramod Abcsdd | Director | - | Past |
| Pramod Abcsdd | Director | 01 Aug 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Symbiotic Therapeutics Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.94% increase. The company also saw a substantial fall in profitability, with a 21.26% decrease in profit. The company's net worth Soared by an impressive increase of 13.9%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Symbiotic Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹9,500,000.00
₹22,004,450.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Apr 2005 | Punjab National Bank | ₹9.50 M | Open |
| 20 Jun 2019 | Others | ₹2.50 M | Satisfied |
| 26 Oct 2018 | Others | ₹1.00 M | Satisfied |
| 30 Jan 2013 | Punjab National Bank | ₹0.85 M | Satisfied |
| 08 Aug 2008 | Member Secretary | ₹1.51 M | Satisfied |
Explore comprehensive loan charge details -
Symbiotic Therapeutics has a workforce of 144 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Symbiotic Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Symbiotic Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Symbiotic Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Progress on Symbiotic Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.
A charge registered on 26 Oct 2018 via Charge ID 100224139 with Others was fully satisfied on 21 Oct 2024. was recorded as a recent event.
Progress on A charge registered on 20 Jun 2019 via Charge ID 100271363 with Others was fully satisfied on 16 Oct 2024. was documented.
A charge registered on 30 Jan 2013 via Charge ID 10402647 with Punjab National Bank was fully satisfied on 29 Jul 2019. was recorded as a recent event.
A charge with Others amounted to Rs. 2.50 M with Charge ID 100271363 was registered on 20 Jun 2019. was recorded as a recent event.
The CIN of Symbiotic Therapeutics Private Limited is U51109DL2000PTC106441.
Symbiotic Therapeutics Private Limited is headquartered at 305Mahajan Tower Plot No 7 L.Sc Shreshtha Vihar, New Delhi, Delhi, 110092.
Symbiotic Therapeutics Private Limited was incorporated on 23 June 2000.
The current directors of Symbiotic Therapeutics Private Limited are
The primary industry of Symbiotic Therapeutics Private Limited is Manufacturing.
Symbiotic Therapeutics Private Limited is unlisted.
The authorized capital of Symbiotic Therapeutics Private Limited is ₹3.00 M, and the paid-up capital is ₹3.00 M.
The compliance status of Symbiotic Therapeutics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX